$4.0M
NovaQuest led the financing round, which drew participation from eight investors across three continents.
Veterinary diagnostic technology developer improving animal health outcomes through early disease detection.
MI:RNA develops veterinary diagnostic technology that uses microRNA biomarkers and blood samples to detect diseases early across the pet, agricultural, and equine sectors.
Eve Hanks
CEO and founder
Eve brings biotechnology and veterinary experience as CEO and founder of MI:RNA, alongside non-executive and advisory roles. She previously worked as a veterinary surgeon across various companies and FirstVet.
LinkedInNovaQuest led the financing round, which drew participation from eight investors across three continents.